Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-12
2006-09-12
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S219000, C514S249000, C540S546000, C540S555000, C540S578000, C544S246000
Reexamination Certificate
active
07105506
ABSTRACT:
Compounds of structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents.
REFERENCES:
patent: 5859006 (1999-01-01), Daugan
patent: 5981527 (1999-11-01), Daugan et al.
patent: 6046199 (2000-04-01), Pamukcu et al.
patent: 100 21 266 (2000-11-01), None
Fantauzzi and Yager “Synthesis of Diverse Tetrahydro-β-Carboline-3-Carboxamides and -2,3-Bis-lactams On a Versatile 4-Hydroxythiophenol-Linked Solid Support” Tetrahedron Letters, vol. 39, pp. 1291-1294 (1998).
Wang and Ganesan “The N-Acyliminium Pictet-Spengler Condensation as a Multicomponent Combinatorial Reaction on Solid Phase and Its Application to the Synthesis of Demethoxyfumitremorgin C Analogues” Organic Letters, vol. 1(10), pp. 1647-1649 (1999).
Wang et al, “Synthesis and Evaluation of Tryprostatin B and Demethoxyfumitremorgin C Analogues” Journal of Medicinal Chemistry, vol. 43, pp. 1577-1585 (2000).
Orme Mark W.
Sawyer Jason S.
Schultze Lisa M.
Lilly Icos LLC
Marshall & Gerstein & Borun LLP
Tucker Zachary
Wilson James O.
LandOfFree
Tetracyclic compounds as PDE5-inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetracyclic compounds as PDE5-inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracyclic compounds as PDE5-inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3529321